Veritas Pharma Inc.

Recent News

  • Veritas Pharma Enters into Definitive Agreement to Acquire Indigenous Bloom Hemp Corporation

    Vancouver, British Columbia--(Newsfile Corp. - September 9, 2020) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VPA) ("Veritas" or the "Company") is pleased to announce that it has entered into a business combination agreement dated September 4, 2020 (the "Business Combination Agreement") to acquire Indigenous Bloom Hemp Corporation ("HempCo") by way of a three cornered amalgamation pursuant to the provisions of the Canada Business Corporations Act. The transaction is at arm's length and constitutes a "fundamental change" under...

    2020-09-09 5:46 PM ET
  • Veritas Pharma Announces Debt Settlement

    Vancouver, British Columbia--(Newsfile Corp. - July 28, 2020) -  Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") wishes to announces that it has entered into debt settlement agreements with directors and officers to settle debt in the amount of $94,750 by the issuance of 1,263,333 common shares at a deemed price of $0.075 per share. The shares will be subject to a four month hold period from the date of issuance.About Veritas PharmaVeritas has...

    2020-07-28 8:31 PM ET
  • Veritas Signs Letter of Intent to Acquire Indigenous Bloom Hemp Corporation

    Vancouver, British Columbia--(Newsfile Corp. - May 22, 2020) - Veritas Pharma Inc.'s (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") is pleased to announce that on May 14th, 2020, the company entered into a Letter of Intent ("LOI") to acquire Indigenous Bloom Hemp Corporation ("HempCo").HempCo operates a large-scale industrial hemp farm in Southern Manitoba on approximately 347 acres of zoned farmland. The primary business of the Company is sale of hemp biomass, flower, and phytocannabinoid rich extracts...

    2020-05-22 4:05 PM ET
  • Veritas Pharma Announces Corrections to Financial Disclosures

    Vancouver, British Columbia--(Newsfile Corp. - May 21, 2020) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") wishes to announce that as a result of a review of its continuous disclosures record by the British Columbia Securities Commission ("BCSC") on May 20th, 2020, the company has amended and re-filed three sets of its interim financial statements and MD&A. for the following dates: October 31, 2018; January 31, 2019; April 30th, 2019.A detailed description of...

    2020-05-21 6:40 PM ET
  • Veritas Pharma Announces Granting of Stock Options

    Vancouver, British Columbia--(Newsfile Corp. - April 27, 2020) -  Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") wishes to announce that it has issued 1,215,789 options to directors and officers of the Company under the stock option plan at an exercise price of $0.15 for a period of 5 years from the date of the grant.About Veritas Pharma Veritas Pharma Inc. has developed intellectual property relating to various cannabis strains. It is the...

    2020-04-27 4:30 PM ET
  • Veritas Pharma Announces New Appointments to the Board of Directors

    Vancouver, British Columbia--(Newsfile Corp. - April 24, 2020) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VPA) ("Veritas" or the "Company") wishes to announce that it has appointed Lorne Mark Roseborough as Chairman of the Board. The Company also wishes to announce the appointment of Sharon Blady as Director. As former Minister of Health in Manitoba, Ms. Blady brings a wide range of experience and expertise in effectively navigating health issues and addressing alternative options for...

    2020-04-24 4:15 PM ET
  • Veritas Pharma Announces Preliminary Clinical Trial Results and the Company's New Direction

    Vancouver, British Columbia--(Newsfile Corp. - February 13, 2020) -  Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") announces its preliminary human study results of its lead cannabis treatment for acute pain, CTL-X, as well as, the Company's new strategy going forward.Preliminary Results of Clinical TrialsThe Company's wholly owned subsidiary, Cannevert Therapeutics Ltd. ("CTL"), identified a lead cannabis strain, CTL-X, as a potential treatment for acute pain from chemical and biological studies. CTL hired Fundación...

    2020-02-13 6:15 PM ET
  • Veritas Announces the Sale of the Sechelt Property

    Vancouver, British Columbia--(Newsfile Corp. - December 9, 2019) - Veritas Pharma Inc.'s (CSE: VRT) (OTC: VRTHF) (Frankfurt: 2VP) ("Veritas" or the "Company") is pleased to announce that its fully owned subsidiary the Sechelt Organic Marijuana Corp. has completed the sale of its property located in Sechelt, BC, to Lis Holdings Ltd. for cash consideration of $350,000.This property was originally purchased in February 2015 with plans to construct a medical cannabis production facility under the ACMPR program. However, due to significant...

    2019-12-09 8:45 AM ET